Glycerin fructose sodium chloride injection and preparation method thereof

A sodium chloride injection, sodium chloride technology, applied in blood diseases, pharmaceutical formulas, extracellular fluid diseases, etc., can solve problems such as removal, inability to make activated carbon, and risks in clinical use, and achieve the goal of improving stability Effect

Inactive Publication Date: 2022-03-11
CISEN PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the common Glycerin Fructose Sodium Chloride Injection often adds activated carbon to absorb bacterial endotoxins, but since the activated carbon cannot be completely removed, there is a risk for clinical use
At the same time, most commercially available varieties do not control the pH value, and adopt the conventional overkill method, resulting in the fact that 5-hydroxymethylfurfural can easily exceed the legal standard within the validity period during the long-term storage process.
The solution to commercially available products is to add antioxidants or other auxiliary materials, but this also brings additional safety risks

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Prescription: glycerin 200g, fructose 100g, sodium chloride 18g, water for injection to 2L.

[0018] The preparation method is: (1) disperse glycerin, fructose, and sodium chloride in water for injection at 30°C, and continue to add water for injection cooled to 30°C to the required prescription amount; (2) add hydrochloric acid or sodium hydroxide solution to adjust the pH (3) The solution is filtered by 0.45μm and 0.22μm two-stage filters and then enters the potting equipment for potting; (4) The potted liquid is sterilized by moist heat sterilization, 121 ° C, F0≥ Sterilize under 8 conditions for 12 minutes.

Embodiment 2

[0020] Prescription: glycerin 200g, fructose 100g, sodium chloride 18g, water for injection to 2L.

[0021] The preparation method is: (1) disperse glycerin, fructose, and sodium chloride in water for injection at 40°C, add water for injection cooled to 40°C to the required prescription amount; (2) add hydrochloric acid or sodium hydroxide solution to adjust the pH value to 4.5; (3) The solution is filtered by 0.45 μm and 0.22 μm two-stage filter elements and then enters the potting equipment for potting; (4) The potted liquid is sterilized by moist heat sterilization, 121 ° C, F0 ≥ 8 Sterilize under conditioned conditions for 12 minutes.

Embodiment 3

[0023] Prescription: glycerin 200g, fructose 100g, sodium chloride 18g, water for injection to 2L.

[0024] The preparation method is: (1) Disperse glycerin, fructose, and sodium chloride in water for injection at 50°C, add water for injection cooled to 50°C to the required prescription amount; (2) add hydrochloric acid or sodium hydroxide solution to adjust the pH value to 5.5; (3) The solution is filtered by 0.45μm and 0.22μm two-stage filter elements and then enters the potting equipment for potting; (4) The potted liquid is sterilized by moist heat sterilization, 121 ° C, F0≥ Sterilize under 8 conditions for 8 minutes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a glycerin fructose sodium chloride injection and a preparation method thereof. The injection comprises the following components: glycerol, fructose, sodium chloride, a pH value regulator and water for injection. An activated carbon-free process is adopted, endotoxin control requirements of a final preparation can be met by controlling endotoxin of raw and auxiliary materials, and meanwhile, the optimal pH value capable of tolerating a moist heat sterilization method is confirmed by screening and researching the pH value of a liquid medicine; the level of the 5-hydroxymethylfurfural can be ensured to meet the requirements in the effective period without additionally adding auxiliary materials, and the stability of the injection and the use safety of a patient are improved.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, in particular to a glycerol fructose sodium chloride injection and a preparation method thereof. Background technique [0002] Glycerin Fructose Sodium Chloride Injection mainly uses its osmotic gradient to dehydrate tissues to exert pharmacological effects. Therefore, as a dehydrating drug, it is often used in the treatment of increased intracranial pressure caused by cerebral hemorrhage, brain tumor, traumatic brain injury, meningitis, etc. Glycerin Fructose Sodium Chloride Injection is a hypertonic preparation, through hypertonic dehydration, it can reduce the water content of the brain and reduce intracranial pressure. Glycerin fructose sodium chloride injection has a slow onset and long duration in reducing intracranial pressure. [0003] At present, the common Glycerin Fructose Sodium Chloride Injection often adds activated carbon to absorb bacterial endotoxins, but si...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/047A61K31/7016A61K47/02A61P7/10
CPCA61K9/08A61K9/0019A61K47/02A61K31/047A61K31/7016A61P7/10A61K2300/00
Inventor 赵元文郑琳琳
Owner CISEN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products